کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1376408 981957 2008 4 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آلی
پیش نمایش صفحه اول مقاله
Benzodiazepine ligands can act as allosteric modulators of the Type 1 cholecystokinin receptor
چکیده انگلیسی

The cholecystokinin (CCK1) receptor is a G protein-coupled receptor important for nutrient homeostasis. The molecular basis of CCK-receptor binding has been debated, with one prominent model suggesting occupation of the same region of the intramembranous helical bundle as benzodiazepines. Here, we used a specific assay of allosteric ligand interaction to probe the mode of binding of devazepide, a prototypic benzodiazepine ligand. Devazepide elicited marked slowing of dissociation of pre-bound CCK, only possible through binding to a topographically distinct allosteric site. This effect was disrupted by chemical modification of a cysteine in the benzodiazepine-binding pocket. Application of an allosteric model to the equilibrium interaction between a series of benzodiazepine ligands and CCK yielded quantitative estimates of each modulator’s affinity for the allosteric site, as well as the degree of negative cooperativity for the interaction between occupied orthosteric and allosteric sites. The allosteric nature of benzodiazepine binding to the CCK1 receptor provides new opportunities for small molecule drug development.

Small molecule benzodiazepine ligands are allosteric modulators of the CCK1 receptor.Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Bioorganic & Medicinal Chemistry Letters - Volume 18, Issue 15, 1 August 2008, Pages 4401–4404
نویسندگان
, , , ,